Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
26/08/2025
Abbott received regulatory approval in Thailand for the first teriparatide biosimilar, expanding access to bone disease treatment medications.
Latest
1 m ago
Philip: Net profit increased by 28.72% year-on-year in the first half of 2025.
2 m ago
Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) obtained the "Drug Registration Certificate" for Saku Polbuxartan Nabbesartan Tablets.
2 m ago
(HEDUAN Intelligence): Net profit for the first half of 2025 was 9.5131 million yuan, a year-on-year decrease of 11.39%.
2 m ago
Suntec Joint Stock Company: The company is not involved in "data center" related business.
2 m ago
New Horizon: Net profit in the first half of 2025 was 60.1657 million yuan, a year-on-year decrease of 23.70%.
See all latest